ActiPatch now officially in Stanford Clinical Tria
Post# of 7791
(Total Views: 695)
Posted On: 04/07/2022 2:17:39 PM
ActiPatch now officially in Stanford Clinical Trial
Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis
Sponsor:
Stanford University
Information provided by (Responsible Party):
Raymond Chou, Stanford University
Device: PEMF device
PEMF device wear overnight daily for four weeks
Other Name: ActiPatch
Long-Term Objective: Determine if high-frequency PEMF therapy reduces pain and improves function in patients with thumb carpometacarpal (CMC) joint osteoarthritis (OA) and if this is secondary to physiological changes.
https://www.clinicaltrials.gov/ct2/show/NCT05315297
Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis
Sponsor:
Stanford University
Information provided by (Responsible Party):
Raymond Chou, Stanford University
Device: PEMF device
PEMF device wear overnight daily for four weeks
Other Name: ActiPatch
Long-Term Objective: Determine if high-frequency PEMF therapy reduces pain and improves function in patients with thumb carpometacarpal (CMC) joint osteoarthritis (OA) and if this is secondary to physiological changes.
https://www.clinicaltrials.gov/ct2/show/NCT05315297
(2)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼